Clinical Trials In Washington, D.C.
Discover hundreds of clinical trials in Washington, D.C..
Search clinical trials in Washington, D.C. by condition or phase.
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
Sponsor:
Abramson Cancer Center at Penn Medicine
Location:
Code:
NCT04841148
Conditions
Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
HCQ
Avelumab
Palbociclib
A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT03871257
Conditions
Low Grade Glioma
Neurofibromatosis Type 1
Visual Pathway Glioma
Eligibility Criteria
Sex: All
Age: 2 - 21
Healthy Volunteers: Not accepted
Interventions
Carboplatin
Magnetic Resonance Imaging
Quality-of-Life Assessment
Questionnaire Administration
Selumetinib Sulfate
STOP-HER2: Stopping Trastuzumab in HER2+ MBC
Sponsor:
Dana-Farber Cancer Institute
Location:
Code:
NCT05721248
Conditions
Breast Cancer
Metastatic Breast Cancer
HER2-positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cessation of anti-HER2 treatment
Phase II Study of PARP Inhibitor Olaparib and IV Ascorbate in Castration Resistant Prostate Cancer
Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Location:
Code:
NCT05501548
Conditions
Prostate Cancer
Castration-resistant Prostate Cancer
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Olaparib
Vitamin C
REFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
Sponsor:
Sutro Biopharma, Inc.
Location:
Code:
NCT05870748
Conditions
Ovarian Cancer
Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Platinum-resistant Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Luveltamab tazevibulin
Pegfilgrastim
Gemcitabine
Paclitaxel
Pegylated liposomal doxorubicin
A Trial of Dabrafenib, Trametinib and Hydroxychloroquine for Patients With Recurrent LGG or HGG With a BRAF Aberration
Sponsor:
Pediatric Brain Tumor Consortium
Location:
Code:
NCT04201457
Conditions
Low Grade Glioma (LGG) of Brain With BRAF Aberration
High Grade Glioma (HGG) of the Brain With BRAF Aberration
Low Grade Glioma of Brain With Neurofibromatosis Type 1
Eligibility Criteria
Sex: All
Age: 1 - 30
Healthy Volunteers: Not accepted
Interventions
Dabrafenib
Trametinib
Hydroxychloroquine
Comparison of Two- Versus Three-antibiotic Therapy for Pulmonary Mycobacterium Avium Complex Disease
Sponsor:
Kevin Winthrop
Location:
Code:
NCT03672630
Conditions
Mycobacterium Avium Complex
Nontuberculous Mycobacterium Infection
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Azithromycin
Ethambutol
Rifampin
Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
Sponsor:
Washington D.C. Veterans Affairs Medical Center
Location:
Code:
NCT06110130
Conditions
Chronic Kidney Diseases
Eligibility Criteria
Sex: All
Age: 19 - 70+
Healthy Volunteers: Not accepted
Interventions
Empagliflozin 10 MG
Placebo
A Study of Multiple Therapies in Biomarker-Selected Patients With Resectable Stages IB-III Non-Small Cell Lung Cancer
Sponsor:
Genentech, Inc.
Location:
Code:
NCT04302025
Conditions
Non-small Cell Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Alectinib
Entrectinib
Vemurafenib (Enrollment closed)
Cobimetinib (Enrollment closed)
Pralsetinib (Enrollment closed)
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Sponsor:
SWOG Cancer Research Network
Location:
Code:
NCT03678025
Conditions
Castration Levels of Testosterone
Metastatic Prostatic Adenocarcinoma
Stage IV Prostate Cancer AJCC v8
Stage IVA Prostate Cancer AJCC v8
Stage IVB Prostate Cancer AJCC v8
Eligibility Criteria
Sex: Male
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Abiraterone
Bicalutamide
Degarelix
Docetaxel
Flutamide